TL;DR:
- Exactech presented 19 new research studies at the 2024 ORS Annual Meeting.
- The research focused on Active Intelligence technologies, Activit-E™ polyethylene, and other innovations.
- Studies demonstrated the precision of computer-assisted navigation in ankle arthroplasty.
- Machine learning enhanced shoulder arthroplasty outcome predictions by analyzing CT images.
- External validation supported the accuracy of Exactech’s Predict+® clinical decision support tool.
- Knee research highlighted the efficacy of ligament-driven knee technology and the Newton® balancing technique.
Main AI News:
Exactech, a leading developer and manufacturer of cutting-edge implants, instrumentation, and intelligent technologies for joint replacement procedures, has announced a remarkable display of 19 pioneering studies on knee, shoulder, and ankle advancements at the 2024 ORS Annual Meeting in California. These studies underscore the transformative potential of Exactech’s Active Intelligence® technologies, Activit-E™ polyethylene, and other offerings.
The research delving into Exactech’s Active Intelligence technologies rigorously assessed the precision and efficacy of various tools, including computer-assisted navigation and patient communication systems. Notably, a study examining the application of computer-assisted surgical systems for total ankle arthroplasty revealed minimal resection errors of less than 2mm and 2°, underscoring the precision achieved through navigation techniques.
Among the groundbreaking shoulder studies presented, machine learning emerged as a pivotal tool for analyzing CT image-based muscle features. By leveraging this technology, researchers were able to enhance predictions regarding muscle size, shape, and quality, thereby refining the accuracy of shoulder arthroplasty outcomes. Additionally, a landmark study provided external validation for the Predict+® clinical decision support tool, affirming its accuracy and reliability in a prospective study involving 243 patients.
Chris Roche, Senior Vice President, Extremities at Exactech, emphasized the company’s commitment to advancing clinical outcomes research and harnessing machine learning capabilities to drive innovation. Roche highlighted the significance of the team’s computer vision endeavors, which aim to extract valuable insights from CT images, thereby enriching clinical understanding and informing the development of future software tools.
In the realm of knee research, Exactech’s ligament-driven knee technology garnered significant attention. Studies showcased the system’s ability to characterize the knee laxity signature and highlighted the swift learning curve associated with adopting the Newton® balancing technique. Laurent Angibaud, Exactech Vice President of Development, Advanced Surgical Technologies, expressed enthusiasm for the studies’ implications in tailoring joint replacement procedures to individual patient needs, particularly in the realm of knee laxity research.
Exactech’s robust presence at the 2024 ORS Annual Meeting reflects its unwavering commitment to pioneering research and innovation in orthopedic surgery. By harnessing the power of AI and machine learning, Exactech continues to revolutionize the field, offering surgeons unparalleled precision and patients superior outcomes.
Conclusion:
Exactech’s comprehensive showcase at the 2024 ORS Annual Meeting underscores its commitment to innovation in orthopedic surgery. The integration of AI technologies, such as machine learning and computer-assisted navigation, not only enhances precision but also enables personalized treatment approaches. This signals a significant advancement in the orthopedic market, where surgeons and patients alike benefit from tailored solutions and improved clinical outcomes.
